Efficacy of Linvoseltamab in Prespecified High Risk Subgroups of Patients with Relapsed/Refractory Multiple Myeloma: Results from LINKER-MM1
Attaya Suvannasankha,Hans Lee,Naresh Bumma,Madhav V. Dhodapkar,Joshua Richter,James E. Hoffman,Mansi Shah,Suzanne Lentzsch,Jeffrey Zonder,Rachid Baz,Joseph J. Maly,Swathi Namburi,Ka Lung Wu,Matthew Pianko,Rebecca Silbermann,Chang-Ki Min,Marie-Christiane Vekemans,Markus Munder,Joaquin Martinez Lopez,Michelle DeVeaux,Dhruti Chokshi,Anita Boyapati,Glenn S. Kroog,Yariv Houvras,Sundar Jagannath CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）
AI 理解论文
溯源树
样例
